Granulomatous prostatitis following Bacillus Calmette-Guérin therapy

Siddhi Hegde1, Dhairya A Lakhani2, Ion Prisneac3

  • 1Department of Radiology, Massachusetts General Hospital, Boston, United States.

PubMed

Insights

Granulomatous prostatitis (GP), a rare chronic prostatitis, presents imaging features that overlap with prostate cancer. Definitive diagnosis requires biopsy, even with suspicious MRI findings.

Area of Science:

  • Urology
  • Radiology
  • Pathology

Background:

  • Granulomatous prostatitis (GP) is a rare condition, affecting 0.65-1.5% of men with chronic prostatitis.
  • Radiological findings of GP often mimic those of prostate adenocarcinoma, posing a diagnostic challenge.

Observation:

  • Magnetic resonance imaging (MRI) may reveal diffuse or focal nodular low T2 signal.
  • Diffusion-weighted imaging (DWI) can show high signal intensity with corresponding low apparent diffusion coefficient (ADC) values.
  • Post-contrast imaging might demonstrate lesion enhancement or rim enhancement, suggestive of caseous necrosis or abscess formation.

Findings:

  • The case involved a 70-year-old male with granulomatous prostatitis.
  • The patient had a history of intravesicle bacillus Calmette-Guérin (BCG) administration.
  • Overlapping imaging features between GP and prostate adenocarcinoma necessitate further investigation.

Implications:

  • Suspicion of GP based on MRI requires biopsy for accurate diagnosis.
  • Understanding these imaging characteristics aids in differentiating GP from prostate cancer.
  • Prior intravesicle BCG administration is a relevant clinical context for GP presentation.